Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

LB PHARMACEUTICALS INC Filed Acc 0001493152-26-052394

Stakes reported in this filing

Reporting person Shares Of the class
Trails Edge Capital Partners, LP 1,149,240 3.6%
Trails Edge Biotechnology Master Fund, LP 1,149,240 3.6%
Ortav Yehudai 1,149,240 3.6%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…